Official release · Court opinion
RN Collins (Series 3) No.9: Psychedelic Licensing Equity: What Cannabis’s Experience May Predict
RN Collins has written a new series (3) of 18 articles for cannabis law report on 2026 Psychedelics & Legal Issues.
Articles
Articles
200 articles
What’s changing in cannabis law: our editors’ articles, and announcements straight from regulators, courts, governments and companies.
38 articles
Press release · GlobeNewswire
Clearmind Advances Dialogue with U.S. Federal Government on Psychedelic Therapies, Submitting Recommendations to FDA
Company Calls for Consideration of New Regulatory Pathways and Cost Saving of Non-Hallucinogenic Neuroplastogens for Alcohol Use Disorder
Press release · GlobeNewswire
MAPS and International Alliance of Psychedelic Therapy Practitioners Announce Partnership to Advance Training for Psychedelic-Assisted Therapy
Collaboration will increase access to practitioner education in the United States and internationally
Press release · PR Newswire
And the point is exactly? Luminous Mind, Inc. Announces U.S. Patent for Non-Hallucinogenic Psychedelic Mushrooms
Not sure how they can call themselves luminous mind when they are taking away the luminosity.
Official release · oregonlegislature.gov
RN Collins (Series 3) No.8: No Standard of Care, No Medical Status, Full Liability: The Facilitator Malpractice Question Oregon’s Framework Raises
RN Collins has written a new series (3) of 18 articles for cannabis law report on 2026 Psychedelics & Legal Issues.
Press release · nextinvestors.com
EMD opens Sydney clinic – now in Australia’s four most populated states
Our psychedelic and mental health Investment Emyria (ASX: EMD) just opened its Sydney Empax clinic, with first patients already in treatment.
Press release · GlobeNewswire
Clearmind Enhances U.S. IP Presence with Publication of Three Patent Applications Covering LSD, Ketamine and Ibogaine Combinations
I think they used to call this Candyflipping…ok not exactly but you know what I’m driving at. Sort of thing they used to bang you up in the states for 300 years for being a menace to society.
Official release · Court opinion
RN Collins (Series 3) No.7 – Federal Regulatory Standards After the MDMA Rejection: What FDA’s Complete Response Letter May Mean for the Psychedelic Pipeline
RN Collins has written a new series (3) of 18 articles for cannabis law report on 2026 Psychedelics & Legal Issues.
Official release · Regulator bulletin
Official Statement “Oregon Health Authority (OHA) will not be moving forward with the current psilocybin rulemaking process that would have included increased license fees.”
Oregon Health Authority (OHA) will not be moving forward with the current psilocybin rulemaking process that would have included increased license fees.
Official release · Regulator bulletin
Alert: The September 2026 Public Comment Period for Oregon Psilocybin Services proposed rules will close on Monday, September 21st 2026 at 5:00pm
The September 2026 Public Comment Period for Oregon Psilocybin Services proposed rules will close on Monday, September 21st 2026 at 5:00pm (Pacific Time).
Press release · fidelity.com
Clearmind Medicine Delivers Briefing to FDA Following Invitation to Historic Psychedelic Hearing in Washington, D.C.
Mary-Elizabeth Gifford, Chief of Global Impact at Clearmind Medicine ( CMND ), spoke on patient access and shared insights from Clearmind’s clinical trial at Yale and Johns Hopkins
Official release · Regulator bulletin
Public Testimony Against Rising Psilocybin Fees in Oregon
The first of two public hearings on proposed rules will begin tonight at 6:00pm (Pacific Time).
Official release · US Department of Justice
Owner of Illicit Drug Website Charged with Trafficking DMT and MDMA Near D.C. College Campus
WASHINGTON — Perry Young, owner and operator of the website “Forest Floor DC,” was charged in an indictment unsealed today for alleged drug trafficking operations involving illegal narcotics, including DMT, MDMA, marijuana, and…
Press release · Business Wire
Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval COMP360 Provider Training
Five organizations awarded grants, above the planned three, as a result of a competitive selection process with highly qualified applicants
Press release · Cannabis Law Report
Australia: Psychedelic-Assisted Therapies Now Reaching Hundreds of Australians as Global Momentum Accelerates
Psychedelic-Assisted Therapies Now Reaching Hundreds of Australians as Global Momentum Accelerates
Official release · wa.gov.au
West Australai Police testing drivers for cocaine on roads across the State
Western Australian drivers with cocaine in their system will now be detected as part of new roadside drug testing, strengthening laws to identify drivers who are affected by illicit drugs.
Official release · federalregister.gov
RN Collins (Series 3) No.4: The Cognitive Liberty Claim: Schedule I Prohibition, Neurological Autonomy, and the Constitutional Lacuna at the Boundary of Thought and Conduct
RN Collins has written a new series (3) of 18 articles for cannabis law report on 2026 Psychedelics & Legal Issues.
Official release · Regulator bulletin
Announcement: Oregon Psilocybin Services merge into Medical Cannabis & Psilocybin (MCAP) section.
Today, September 1, 2026, marks the beginning of a new chapter for the Oregon Medical Marijuana Program (OMMP) and the Oregon Psilocybin Services (OPS) section as we merge into the Medical Cannabis & Psilocybin (MCAP) section.
Official release · Regulator bulletin
September 2026 Public Comment Period for Oregon Psilocybin Services proposed rules is now open
The September 2026 Public Comment Period for Oregon Psilocybin Services proposed rules is now open. The proposed rules include significant increases to all fees and elimination of reduced fees.
Press release · GlobeNewswire
University of Miami’s Gift of 1994 Ibogaine IND to HHS Sets a Standard for Open Science
MAPS provided the first outside funding for the University of Miami ibogaine research program in the 1990s
20 of 38